MDLN logo

Medline Inc. (MDLN)

$32.37

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on MDLN

Market cap

$42.56B

EPS

1.43

P/E ratio

145

Price to sales

2.15

Dividend yield

--

Beta

-0.478571

Price on MDLN

Previous close

$32.38

Today's open

$32.13

Day's range

$32.06 - $32.72

52 week range

$31.49 - $50.88

Profile about MDLN

CEO

--

Employees

43000

Headquarters

Northfield, IL

Exchange

Nasdaq Global Select

Shares outstanding

1.31B

Issue type

Common Stock

MDLN industries and sectors

Healthcare

Medical Equipment & Supplies

News on MDLN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

news source

PRNewsWire • 15 hours ago

news preview

$MDLN Stock Market Alert: Medline Investigated for Securities Fraud after Product Quality Issues Lead to 13% Stock Drop – Contact BFA Law if You Lost Money

NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.

news source

GlobeNewsWire • Oct 28, 2026

news preview

$MDLN Stock Losses: BFA Law Reminds Medline Investors with Losses of the Ongoing Securities Fraud Investigation into Potential Product Quality Misrepresentations

NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.

news source

GlobeNewsWire • Oct 26, 2026

news preview

MDLN Investigation News: Medline Investors are Notified of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money

NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.

news source

GlobeNewsWire • Oct 23, 2026

news preview

MDLN Loss Notice: Medline Investors are Reminded of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money

NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.

news source

GlobeNewsWire • Oct 21, 2026

news preview

MDLN Investigation Reminder: Medline Investors that Lost Money after the 13% Stock Drop are Notified to Contact BFA Law

NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.

news source

GlobeNewsWire • Oct 19, 2026

news preview

MDLN Securities Announcement: Medline Investors with Losses may have Rights in an Ongoing Securities Fraud Investigation – Contact BFA Law

NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.

news source

GlobeNewsWire • Oct 16, 2026

news preview

Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.

State-of-the-art facility planned to reinforce Medline's supply chain resilience in Michigan NORTHFIELD, Ill., Oct. 15, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, has announced plans to open a new distribution center in Van Buren Township, Mich.

news source

PRNewsWire • Oct 15, 2026

news preview

$MDLN Investors: A Securities Fraud Investigation is Pending on behalf of Medline Investors that Lost Money after 13% Stock Drop – Contact BFA Law

NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-lawsuit.

news source

GlobeNewsWire • Oct 14, 2026

news preview

Medline Inc. Investigation Continues: Investors May Contact Kirby McInerney LLP, a Securities Fraud Law Firm, If You Lost Money On Your MDLN Investments

New York, New York--(Newsfile Corp. - October 13, 2026) - The law firm of Kirby McInerney LLP continues its investigation on behalf of Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices. [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Happened?

news source

Newsfile Corp • Oct 13, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Medline Inc.

Open an M1 investment account to buy and sell Medline Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in MDLN on M1